News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
731,057 Results
Type
Article (41376)
Company Profile (264)
Press Release (689401)
Multimedia
Podcasts (92)
Webinars (20)
Section
Business (204880)
Career Advice (2032)
Deals (35592)
Drug Delivery (131)
Drug Development (81528)
Employer Resources (173)
FDA (16512)
Job Trends (14988)
News (346888)
Policy (32755)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2596)
Accelerated approval (47)
Adcomms (26)
Allergies (171)
Alliances (49595)
ALS (211)
Alzheimer's disease (1800)
Antibody-drug conjugate (ADC) (448)
Approvals (16899)
Artificial intelligence (663)
Autoimmune disease (293)
Automation (56)
Bankruptcy (362)
Best Places to Work (11637)
BIOSECURE Act (20)
Biosimilars (222)
Biotechnology (171)
Bladder cancer (195)
Brain cancer (72)
Breast cancer (751)
Cancer (5828)
Cardiovascular disease (470)
Career advice (1724)
Career pathing (42)
CAR-T (331)
CDC (56)
Celiac Disease (3)
Cell therapy (898)
Cervical cancer (47)
Clinical research (70856)
Collaboration (2060)
Company closure (5)
Compensation (1403)
Complete response letters (80)
COVID-19 (2744)
CRISPR (108)
C-suite (1129)
Cystic fibrosis (152)
Data (7923)
Decentralized trials (3)
Denatured (27)
Depression (161)
Dermatology (86)
Diabetes (586)
Diagnostics (6927)
Digital health (55)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (318)
Drug pricing (200)
Drug shortages (31)
Duchenne muscular dystrophy (283)
Earnings (92116)
Editorial (66)
Employer branding (21)
Employer resources (152)
Events (119551)
Executive appointments (1083)
FDA (20247)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (18)
Frontotemporal dementia (34)
Funding (1726)
Gene editing (234)
Generative AI (56)
Gene therapy (722)
GLP-1 (1055)
Government (4733)
Grass and pollen (6)
Guidances (408)
Healthcare (19006)
HIV (79)
Huntington's disease (56)
IgA nephropathy (97)
Immunology and inflammation (288)
Immuno-oncology (93)
Indications (194)
Infectious disease (3082)
Inflammatory bowel disease (216)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (290)
Interviews (319)
IPO (16668)
IRA (50)
Job creations (3651)
Job search strategy (1430)
JPM (58)
Kidney cancer (19)
Labor market (101)
Layoffs (563)
Leadership (39)
Legal (7953)
Liver cancer (100)
Longevity (32)
Lung cancer (765)
Lymphoma (429)
Machine learning (60)
Management (59)
Manufacturing (1050)
MASH (188)
Medical device (13932)
Medtech (14057)
Mergers & acquisitions (20177)
Metabolic disorders (1501)
mRNA (205)
Multiple sclerosis (188)
NASH (17)
Neurodegenerative disease (417)
Neuropsychiatric disorders (105)
Neuroscience (3310)
Neurotech (1)
NextGen: Class of 2026 (6520)
Non-profit (4530)
Now hiring (78)
Obesity (702)
Opinion (288)
Ovarian cancer (220)
Pain (256)
Pancreatic cancer (304)
Parkinson's disease (362)
Partnered (33)
Patents (595)
Patient recruitment (672)
Peanut (62)
People (59613)
Pharmaceutical (58)
Pharmacy benefit managers (32)
Phase 1 (22085)
Phase 2 (31218)
Phase 3 (23225)
Pipeline (8790)
Policy (318)
Postmarket research (2569)
Preclinical (9416)
Press Release (64)
Prostate cancer (304)
Psychedelics (54)
Radiopharmaceuticals (323)
Rare diseases (1077)
Real estate (5973)
Recruiting (70)
Regulatory (25416)
Reports (56)
Research institute (2412)
Resumes & cover letters (353)
Rett syndrome (39)
RNA editing (22)
RSV (88)
Schizophrenia (176)
Series A (288)
Series B (213)
Service/supplier (11)
Sickle cell disease (112)
Special edition (24)
Spinal muscular atrophy (166)
Sponsored (48)
Startups (3640)
State (2)
Stomach cancer (18)
Supply chain (127)
Tariffs (87)
The Weekly (63)
Vaccines (1091)
Venture capital (108)
Weight loss (451)
Women's health (128)
Worklife (20)
Date
Today (168)
Last 7 days (815)
Last 30 days (3625)
Last 365 days (30196)
2026 (12716)
2025 (30174)
2024 (35212)
2023 (40074)
2022 (51176)
2021 (55713)
2020 (54083)
2019 (46539)
2018 (35018)
2017 (32118)
2016 (31489)
2015 (37556)
2014 (31319)
2013 (26346)
2012 (28572)
2011 (29268)
2010 (27334)
Location
Africa (741)
Alabama (93)
Alaska (7)
Arizona (348)
Arkansas (14)
Asia (39695)
Australia (6512)
California (13303)
Canada (3772)
China (1343)
Colorado (567)
Connecticut (579)
Delaware (410)
Europe (85932)
Florida (1992)
Georgia (426)
Hawaii (3)
Idaho (62)
Illinois (1051)
India (90)
Indiana (601)
Iowa (23)
Japan (540)
Kansas (131)
Kentucky (50)
Louisiana (41)
Maine (76)
Maryland (1593)
Massachusetts (9489)
Michigan (364)
Minnesota (719)
Mississippi (6)
Missouri (144)
Montana (33)
Nebraska (29)
Nevada (143)
New Hampshire (84)
New Jersey (3497)
New Mexico (29)
New York (3482)
North Carolina (1689)
North Dakota (9)
Northern California (6672)
Ohio (399)
Oklahoma (23)
Oregon (41)
Pennsylvania (2677)
Puerto Rico (29)
Rhode Island (50)
South America (1112)
South Carolina (86)
South Dakota (2)
Southern California (5250)
Tennessee (212)
Texas (2122)
United States (46923)
Utah (396)
Vermont (1)
Virginia (322)
Washington D.C. (80)
Washington State (1061)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
731,057 Results for "lonza inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products
April 21, 2026
·
6 min read
Press Releases
Octane Medical Group Signs Agreement to Acquire Lonza’s Personalized Medicine Business
March 4, 2026
·
3 min read
Press Releases
StarLIMS to Acquire the MODA® Platform from Lonza, Expanding Deeper Into Manufacturing Operations & Quality Control
March 25, 2026
·
2 min read
Press Releases
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG
March 9, 2026
·
2 min read
Deals
What Lonza’s $1.2B Buy of Roche Biologics Plant Means for CDMO Market
The Swiss contract manufacturer’s cash deal for Roche’s facility in Vacaville, California, is one of the world’s largest manufacturing sites for biologics—a major growth driver for Lonza and other CDMOs.
March 28, 2024
·
5 min read
·
Tyler Patchen
Press Releases
Ethris and Lonza Collaborate to Develop Spray-Dried mRNA Vaccines for Respiratory Disease Prevention
April 7, 2025
·
4 min read
Business
Lonza Projects Flat Sales for 2024 as CDMOs Look to Recover from 2023
While the company expects sales growth to be flat this year, Lonza’s shares jumped around 14% Friday morning after reporting full-year 2023 sales of $7.75 billion, which was 3% above the consensus.
January 26, 2024
·
1 min read
·
Kate Goodwin
Deals
Lonza to Buy Roche Biologics Manufacturing Site in California for $1.2B
The contract manufacturer plans to expand its U.S. footprint with a former Roche facility in Vacaville, California, which Lonza contends is one of the largest biologics manufacturing facilities in the world by volume.
March 20, 2024
·
1 min read
·
Tyler Patchen
Business
Acumen Pharmaceuticals Collaborates with Lonza to Advance Sabirnetug for the Treatment of Alzheimer’s Disease
Acumen Pharmaceuticals, a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer’s disease (AD), has signed a collaboration agreement with Lonza, a global partner to the pharmaceutical, biotech and nutraceutical markets.
April 4, 2024
·
6 min read
Press Releases
TriLink BioTechnologies® and Lonza Enter into Non-exclusive License and Supply Agreement for CleanCap® mRNA Capping Technology
TriLink BioTechnologies, a Maravai™ LifeSciences company and global provider of life science reagents and services, has signed a non-exclusive License and Supply Agreement with Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries.
April 30, 2024
·
2 min read
1 of 73,106
Next
